Bayesian Capital Management’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,476
Closed -$73K 997
2022
Q3
$73K Buy
+1,476
New +$73K 0.01% 615